These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24716007)

  • 1. Multifactorial hypercalcemia and literature review on primary hyperparathyroidism associated with lymphoma.
    Maletkovic J; Isorena JP; Palma Diaz MF; Korenman SG; Yeh MW
    Case Rep Endocrinol; 2014; 2014():893134. PubMed ID: 24716007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Hyperparathyroidism With Undetectable Intact Parathyroid Hormone.
    Song Z; McMullin J; Huls F; Rosenthal R; Bantu S; Wu C; Chen H; Lindeman B
    Clin Med Insights Endocrinol Diabetes; 2024; 17():11795514241290125. PubMed ID: 39381434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with clear cell renal carcinoma.
    Gomes Lda S; Kulak CA; Costa TM; Vasconcelos EC; Carvalho Md; Borba VZ
    Arch Endocrinol Metab; 2015 Feb; 59(1):84-8. PubMed ID: 25926120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine Carcinoma as a Cause of Humoral Hypercalcemia of Malignancy: A Case of a Patient With Elevated Parathyroid Hormone-Related Protein.
    Christensen BR; Rendo MJ; Beeler BW; Huddleston BJ; Fenderson JL
    Cureus; 2022 Mar; 14(3):e23398. PubMed ID: 35481321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressibility of parathyroid hormone in primary hyperparathyroidism.
    Khoo TK; Baker CH; Abu-Lebdeh HS; Wermers RA
    Endocr Pract; 2007; 13(7):785-9. PubMed ID: 18194938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature.
    Nakajima K; Tamai M; Okaniwa S; Nakamura Y; Kobayashi M; Niwa T; Horigome N; Ito N; Suzuki S; Nishio S; Komatsu M
    Endocr J; 2013; 60(5):557-62. PubMed ID: 23303131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level.
    Gurrado A; Marzullo A; Lissidini G; Lippolis A; Rubini D; Lastilla G; Testini M
    World J Surg Oncol; 2008 Feb; 6():24. PubMed ID: 18291038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms and treatment of hypercalcemia of malignancy.
    Clines GA
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report.
    Marstrand SD; Tofteng CL; Jarløv A; Borgwardt L; Schwarz P
    J Med Case Rep; 2021 Sep; 15(1):471. PubMed ID: 34556169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic approach to hypercalcemia: relevance of parathyroid hormone and parathyroid hormone-related protein measurements.
    Casez J; Pfammatter R; Nguyen Q; Lippuner K; Jaeger P
    Eur J Intern Med; 2001 Jul; 12(4):344-349. PubMed ID: 11395297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
    Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
    J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent hypercalcemia due to ectopic production of parathyroid hormone-related protein and intact parathyroid hormone in a single patient with multiple malignancies.
    Eid W; Wheeler TM; Sharma MD
    Endocr Pract; 2004; 10(2):125-8. PubMed ID: 15256329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcemia with low-normal serum intact PTH: a novel presentation of primary hyperparathyroidism.
    Hollenberg AN; Arnold A
    Am J Med; 1991 Nov; 91(5):547-8. PubMed ID: 1951417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of primary hyperparathyroidism in treated breast cancer.
    Fierabracci P; Pinchera A; Miccoli P; Conte PF; Vignali E; Zaccagnini M; Marcocci C; Giani C
    J Endocrinol Invest; 2001 May; 24(5):315-20. PubMed ID: 11407650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism.
    Firek AF; Kao PC; Heath H
    J Clin Endocrinol Metab; 1991 Mar; 72(3):541-6. PubMed ID: 1997510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D metabolism in familial benign hypercalcemia (hypocalciuric hypercalcemia) differs from that in primary hyperparathyroidism.
    Law WM; Bollman S; Kumar R; Heath H
    J Clin Endocrinol Metab; 1984 Apr; 58(4):744-7. PubMed ID: 6699136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia type 1.
    Milanesi A; Yu R; Geller SA; Burton D; Deftos LJ; Wolin EM
    Pancreas; 2011 May; 40(4):634-7. PubMed ID: 21483254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercalcemia of Malignancy and Colorectal Cancer.
    Galindo RJ; Romao I; Valsamis A; Weinerman S; Harris YT
    World J Oncol; 2016 Feb; 7(1):5-12. PubMed ID: 26998187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalcemia and parathyroid disorders.
    Endres DB
    Curr Opin Rheumatol; 1992 Jun; 4(3):383-8. PubMed ID: 1599819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer presenting with hypercalcemia: two cases with similar manifestations but different mechanisms.
    Ma X; Wang Y; Zhang X; Dong M; Yang W; Xue F
    Cancer Biol Med; 2018 May; 15(2):182-187. PubMed ID: 29951343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.